Future science OA
Clinical efficacy of 2-week and 3-week albumin-bound paclitaxel therapy for advanced pancreatic cancer.
Zhimin Su, Jiana Jiang, Feng Shen, Zhiyong Li
Published: 202610.1080/20565623.2026.2617117
Abstract
OBJECTIVE: We aim to compare the clinical efficacy and safety of albumin-bound paclitaxel (nab-PTX) (125 mg/m2, q2w) for two weeks and (125 mg/m2, d1, d8, q3w) for three weeks in the first-line treatment of advanced pancreatic cancer. METHODS: The me…
Preview only. Read the full abstract at the source